HROW

HROW

HROW

Letters With This Ticker

Quarter Letter Date Fund Name QTD YTD Tickers Keywords/Themes Theme Commentary Pitches Letter
2023 Q2 Aug 31, 2023 SRK Capital 0.0% 17.2% HGBL, HROW, SGMA, SRDX, VASO -
2022 Q4 Feb 16, 2023 SRK Capital 0.0% 17.2% HGBL, HROW, JOB, MLC CN -
2023 Q4 Jan 2, 2024 SRK Capital 0.0% 17.2% HGBL, HROW, ISSC, SGMA, VASO -

Pitches With This Ticker

Date Pitch Type Author Company Industry Sub Industry Bull / Bear Stock Exchange Keywords Action
Oct 30, 2025 Value Investors Club ppsm920 Harrow, Inc. Health Care Pharmaceuticals Bull NASDAQ Anesthesia, Biosimilars, Ophthalmology, Specialty pharma
Sep 16, 2025 Short Thesis Bonitas Harrow Health Inc Health Care Pharmaceuticals Bear NASDAQ acquisition, compounding, Ophthalmology, pharma, Regulation
Aug 8, 2025 Seeking Alpha Quad 7 Capital Harrow, Inc. Other - Bull NASDAQ
Aug 8, 2025 Seeking Alpha Michigan Value Investor Harrow, Inc. Health Care Drug Manufacturers - Specialty & Generic Bull NASDAQ
Aug 7, 2025 Seeking Alpha The Undercovered Dozen Harrow, Inc. Health Care Drug Manufacturers - Specialty & Generic Bull NASDAQ

BSD Shareholders of HROW

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025
Manager Name Fund Name Fund AUM Invested Value Portfolio Weight Shares Owned Shares Bought / Sold During Quarter % Bought / Sold During Quarter % of Shares Outstanding Owned
No investor data available.